Coca-Cola Embonor Valuation
Is EMBONOR-B undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of EMBONOR-B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: EMBONOR-B (CLP1334) is trading above our estimate of fair value (CLP1041.61)
Significantly Below Fair Value: EMBONOR-B is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EMBONOR-B?
Other financial metrics that can be useful for relative valuation.
What is EMBONOR-B's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | CL$648.73b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.7x |
Enterprise Value/EBITDA | 1.9x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does EMBONOR-B's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 18.3x | ||
ANDINA-B Embotelladora Andina | 14.3x | 8.1% | CL$2.5t |
CONCHATORO Viña Concha y Toro | 16.9x | 13.6% | CL$886.8b |
HF Hortifrut | 37.8x | n/a | CL$757.2b |
CAROZZI Carozzi | 4.4x | n/a | CL$391.5b |
EMBONOR-B Coca-Cola Embonor | 8.5x | n/a | CL$648.7b |
Price-To-Earnings vs Peers: EMBONOR-B is good value based on its Price-To-Earnings Ratio (8.5x) compared to the peer average (11.9x).
Price to Earnings Ratio vs Industry
How does EMBONOR-B's PE Ratio compare vs other companies in the Global Beverage Industry?
Price-To-Earnings vs Industry: EMBONOR-B is good value based on its Price-To-Earnings Ratio (8.5x) compared to the Global Beverage industry average (18.9x).
Price to Earnings Ratio vs Fair Ratio
What is EMBONOR-B's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 8.5x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate EMBONOR-B's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.